Home / Evidence

The Evidence, Graded by Condition

Each grade below (Strong, Moderate, Limited or Insufficient) is a summary of how many controlled human trials exist for that condition and whether their doses match a home panel; see how this site grades evidence for the hierarchy and a worked example at each level.

Every clinical claim carries a PMID. Grades reflect trial quality and replication, not marketing.

Red light therapy evidence varies sharply by condition: skin, hair loss, wound healing, and knee osteoarthritis carry controlled-trial support; sleep, psoriasis, and mood are early; weight loss and testosterone claims lack credible support at consumer-device doses. Each page grades the evidence and cites the underlying studies.

How the grades work

Each condition page opens with one of four grades. Strong means more than one controlled trial points the same way at doses a home panel can deliver. Moderate means controlled trials exist but are few, small, or used clinic devices whose parameters differ from home panels. Limited means the support is pilot studies, single trials, or trials at parameters a panel cannot match. Insufficient means no credible trial evidence was found for the claim, whatever the marketing says. Every study named on a condition page carries its PubMed ID, the ID is verified against PubMed before the page is published, and the page states the wavelength, dose and session count the trial used so it can be compared with a real panel through the dose calculator.

Reading a condition page

The order is the same on every page: the grade and why, the studies, what was not studied, a practical section linking the calculator and the wavelength guide, then cautions. A grade is a statement about the trials, not a promise about a device; a Strong grade with a device whose irradiance is unlabeled still leaves the dose unknown, which is why the device picks on these pages come from the ranked database rather than from the trials themselves.

Latest evidence articles

Flow diagram of a 2024 meta-analysis on photobiomodulation added to basic periodontal therapy, from 947 references to 13 studies in the pooled analysis
October 30, 2026

Photobiomodulation for Periodontitis: Dental-Office Evidence

Evidence grade Moderate for photobiomodulation added to basic periodontal therapy in a clinic, from a 2024 meta-analysis, and what it means for home panels.

Two boxes summarizing the MASCC/ISOO guideline review and the tumor safety review on oral mucositis
October 29, 2026

Photobiomodulation for Oral Mucositis: Clinic Evidence

Evidence grade Strong for supervised clinic use in cancer care, from the MASCC/ISOO review, with what it does and does not say about home panels.

Trial map of a five-patient dementia case series and a 40-person healthy-adult laser trial of near-infrared light
October 29, 2026

Red and NIR Light for Cognition and Dementia: Case Series Only

Grade Insufficient. A five-person dementia case series, a 40-person 1064nm laser trial in healthy adults and a narrative review, and what a home panel is not known to do.

Bar chart of pooled limb volume change in mL from a 2015 meta-analysis of low-level laser for lymphedema
October 28, 2026

Red Light Therapy for Breast Cancer Lymphedema

One 2015 meta-analysis of laser therapy for breast cancer-related lymphedema, what clinics used, and why a home panel is a question for oncology.

Design diagram of the 2013 cellulite trial showing 34 laser and 34 sham participants, 532nm green diodes, three sessions over two weeks and a six-week follow-up
October 28, 2026

Red Light Therapy for Cellulite: Limited Evidence

One sham-controlled trial of a 532nm green laser reported cellulite stage improvement. What it measured, what it did not, and what it means for a home panel.

Design diagram of the 1999 Schindl trial: 50 patients, laser versus sham, 690nm daily for two weeks, 52 weeks of follow-up, with median recurrence-free time of 37.5 versus 3 weeks
October 27, 2026

Red Light Therapy for Cold Sores: Limited Evidence

Grade Limited. One 1999 sham-controlled laser trial reported longer recurrence-free time, and no home panel trial exists. What it tested and what is unknown.

Design summary of a 2020 meta-analysis: two randomized trials, 106 participants, outcomes pain, function and radiographic healing
October 26, 2026

Study Review: Light Therapy for Fractures, 2020 Meta-Analysis

A 2020 meta-analysis pooled two placebo-controlled fracture trials. What it asked, what it found, why certainty stayed low, and the gap to a home panel.

Diagram of the fracture photobiomodulation evidence base: two randomized trials, 106 participants, outcomes pain, function and radiographic healing
October 26, 2026

Red Light Therapy and Bone Healing: Limited Evidence

Grade Limited. One 2020 meta-analysis of two placebo-controlled fracture trials reported small pain and function signals and no radiographic difference.

Summary cards of a Cochrane review of laser therapy in rheumatoid arthritis: five trials, 222 patients, and the pain, stiffness and flexibility results
October 25, 2026

Red Light for Rheumatoid Arthritis: The Cochrane Review

A Cochrane review of placebo-controlled laser trials in rheumatoid arthritis reported short-term pain and stiffness changes. Grade Limited. Here is what it covers.

Trial map comparing a 2018 meta-analysis of laser therapy for jaw pain with a 2025 1064nm laser trial, showing design, light source and gaps
October 24, 2026

Red Light Therapy for TMJ Pain: The Evidence

TMJ pain and light therapy graded Moderate for clinic lasers and Insufficient for home panels, with the 2018 meta-analysis and a 2025 1064nm trial.

Trial map of a 36-person randomized comparison of botulinum toxin A and low-level laser in chronic migraine
October 24, 2026

Red Light Therapy for Migraine: What Exists

Migraine evidence grade is Insufficient. One small trial compared laser with botulinum toxin A; no sham-controlled panel trial exists.

Trial map of three systematic reviews on oral photobiomodulation showing the condition, the review, and the device type each one covered
October 23, 2026

Red Light Therapy for Gum and Dental Health

Evidence grade for photobiomodulation in the mouth, from oral mucositis to periodontal care and jaw pain, and why a home panel is not what those trials tested.

Trial map of the 2012 whole-body red light sleep trial in 20 female athletes, with two arms of 10, 30 minutes nightly for 14 nights, and the three outcomes measured
October 23, 2026

Red Light, Melatonin and Circadian Rhythm: Evidence

Grade Limited. One small athlete trial reported higher melatonin after nightly red light; here is what it showed, what it did not, and how to use a panel at night.

Light spectrum chart marking clinic UV, the two blue arms of the AD-Blue eczema trial and the red and near-infrared range of home panels, with an evidence note for each
October 22, 2026

Red Light Therapy for Eczema: Evidence Not There Yet

Grade Insufficient. No randomized red or near-infrared trial for atopic dermatitis was found, and the closest sham-controlled LED trial used blue light.

Trial map of the 2022 meta-analysis showing 11 plantar fasciitis trials among 18 reports, with laser wavelength, power, energy and session ranges
October 21, 2026

Red Light Therapy for Plantar Fasciitis: The Evidence

Plantar fasciitis and red light therapy graded Limited: one 2022 meta-analysis of laser trials, a dose pattern, no panel studies, and practical limits.

Trial map of three Achilles tendon sources: the 2006 seven-patient crossover trial, the 2010 25-trial review and the 2022 meta-analysis with five Achilles trials
October 21, 2026

Red Light Therapy for Achilles Tendinopathy: Evidence

Achilles tendinopathy and red light therapy graded Limited: a pooled pain result, a tiny mechanism trial, laser-only doses, and what a home panel can claim.

Flow diagram from light absorption through ATP, reactive oxygen species, nitric oxide and transcription factors to reported anti-inflammatory effects, with the evidence base marked as cells and animals
October 20, 2026

Study Review: Hamblin's Anti-Inflammatory Mechanisms (2017)

A 2017 review of how red and near-infrared light may lower inflammation: the proposed pathways, the cell and animal evidence, and what it cannot say about a panel.

Trial map of one sham-controlled trial in 47 women and two reviews on red light for female hair loss, with wavelength, dose and design for each
October 20, 2026

Red Light Therapy for Female Pattern Hair Loss: Evidence

Grade Moderate. One sham-controlled trial in 47 women plus two reviews, all on a 655nm helmet. What was studied, what was not, and what it means for a panel.

Design diagram of the LIGHTSITE III trial: 100 people, 148 eyes, 590, 660 and 850nm light versus sham, nine sessions per course, 13 of 24 months reported
October 19, 2026

Study Review: LIGHTSITE III, Dry AMD Light Trial (2024)

A sham-controlled trial of 590, 660 and 850nm light in dry AMD reported a 2.4-letter acuity edge at 13 months, using a clinic device, not a home panel.

Trial map of four photoaging sources: Wunsch 2014 (136 volunteers, red and broadband), Lee 2007 (76 patients, split-face, 830 and 633nm), Weiss 2005 (900 patients, 590nm), Avci 2013 review
October 19, 2026

Red Light Therapy for Photoaging and Sun-Damaged Skin

Grade Limited. Two controlled trials, an uncontrolled clinic report and a review on aging skin, what each tested, and what a home panel can claim.

Two-column diagram contrasting cell and animal mechanism findings from a 2017 review with the design and results of a seven-patient Achilles tendinitis trial that measured prostaglandin E2
October 19, 2026

Red Light Therapy and Inflammation: Mechanism vs Human Data

Grade Limited. Cell and animal work describes how light may lower inflammation; one small human trial measured a marker. What each can and cannot say about a panel.

Trial map of an 11-participant open-protocol study of transcranial red and near-infrared LED treatment for chronic mild traumatic brain injury
October 18, 2026

Red and NIR Light for Traumatic Brain Injury

Grade Limited. One 11-person open-protocol LED study, a narrative review and a penetration paper, and why a home panel cannot be assumed to reach the brain.

Design diagram of the 2014 open-protocol study showing 11 participants, 18 sessions over 6 weeks, 22.2 mW/cm2, 10 minutes per site, about 13 J/cm2 per site and four follow-up test points
October 18, 2026

Study Review: Transcranial LEDs for Chronic Mild TBI (2014)

An 11-person open-protocol study of scalp LEDs in chronic mild brain injury: the dose, the cognitive tests, the missing control group, and the gap to a home panel.

Bar chart of mean change in modified Total Neuropathy Score at 4, 8 and 16 weeks for sham and photobiomodulation groups
October 18, 2026

Study Review: Sham-Controlled PBM for Chemo Neuropathy

A 70-patient sham-controlled trial of photobiomodulation for chemotherapy neuropathy. What it measured, what it left unstated, and the gap to a home panel.

Trial map comparing the 2024 LIGHTSITE III trial (590, 660 and 850nm, sham-controlled, 100 people) with the 2008 case series (780nm laser, 203 patients)
October 18, 2026

Photobiomodulation for Dry Macular Degeneration

Grade Limited. A sham-controlled clinic trial and a 2008 laser case series, both on ophthalmic devices under supervision, and why neither is a home-panel protocol.

Chart of complete healing estimates with confidence intervals from two meta-analyses of low-level laser for diabetic foot ulcers
October 17, 2026

Study Review: Two Meta-Analyses of Light for Foot Ulcers

A 2018 and a 2021 meta-analysis pooled randomized trials of low-level laser for diabetic foot ulcers. Results, limits, and the gap between a clinic laser and a home panel.

Trial map of two meta-analyses on light therapy for diabetic foot ulcers showing 7 trials with 194 patients and 13 trials with 413 patients
October 17, 2026

Red Light Therapy for Diabetic Foot Ulcers: Clinic Evidence

Two meta-analyses of randomized trials link low-level laser to faster diabetic foot ulcer healing, with very low certainty. What was tested, and why a home panel is no substitute.

Trial map of a 70-patient sham-controlled crossover trial of photobiomodulation for chemotherapy-induced neuropathy
October 17, 2026

Red Light Therapy for Chemotherapy-Induced Neuropathy

One sham-controlled trial of 70 patients and one tumor-safety review. What each reported, what was not studied, and why oncology coordination comes first.

Bar chart of mean improvement in inflammatory lesions (77.93 percent) and non-inflammatory lesions (34.28 percent) in the Lee 2007 phototype IV acne trial
October 16, 2026

Study Review: Blue and Red LED for Acne, Phototype IV (2007)

A 2007 trial of 24 patients with skin phototype IV used alternating blue and red LED twice a week for 4 weeks. Design, results, limits and what it means for a panel.

Trial map of the 2018 carpal tunnel laser review showing the very short term, 7 week and 12 week evidence ratings
October 16, 2026

Red Light Therapy for Carpal Tunnel Syndrome

Evidence grade Limited for low-level laser in carpal tunnel syndrome, what the 2018 systematic review found, what was not studied, and what it means for a panel.

Trial map of two tendon laser reviews: the 2015 shoulder meta-analysis of 17 trials (13 high quality, 4 moderate) and the 2010 meta-analysis of 25 tendon trials
October 15, 2026

Red Light Therapy for Shoulder Tendinopathy

Evidence grade Limited to Moderate for laser in shoulder tendinopathy, what the 2015 meta-analysis covered, what was not studied, and what it means for a panel.

Trial map of the thyroid laser randomized trial showing laser and placebo arms, 830 nm, 10 sessions and follow-up points
October 14, 2026

Red Light Therapy for Hypothyroidism: One RCT, Much Caution

Evidence grade Limited. One randomized trial of an 830 nm laser over the thyroid, a long-term follow-up, and why a home panel is not that device.

Bar chart of mean levothyroxine dose in micrograms per day for laser and placebo groups at the trial and at six-year follow-up
October 14, 2026

Study Review: 830 nm Laser in Hashimoto Hypothyroidism

A review of the Hofling 2013 placebo-controlled trial of an 830 nm laser over the thyroid, its parameters, results, limits and what it means for a home panel.

Timeline from a 1971 laser wound-healing paper to a 2001 NASA LED paper, with the gap to home panels marked
October 12, 2026

Study Review: Mester's Lasers (1971) to NASA's LEDs (2001)

Two historical papers behind photobiomodulation, an early laser wound-healing report and a NASA LED review, and what they do and do not say about home panels.

Trial map showing one scar case series, one skin collagen trial and the gaps in scar evidence
October 12, 2026

Red Light Therapy for Scars: Case Series and Collagen

Grade Limited. One small case series on hypertrophic scars and keloids, plus collagen findings from skin trials. No stretch-mark trial was found.

Design diagram of a computer simulation of light in a layered skin model, with wavelength and beam width as the two inputs
October 11, 2026

Study Review: Penetration Modeling by Wavelength (2017)

A 2017 computer simulation of light in skin found depth rose with wavelength and that beams wider than about 10 mm added little. What it can and cannot say.

Trial map of six laser studies on lateral epicondylitis, showing wavelength, design and size
October 10, 2026

Red Light Therapy for Tennis Elbow: The Evidence

Tennis elbow and red light therapy graded Limited: one pooled grip strength result, mixed small laser trials, and no panel studies. Doses and gaps.

Design diagram of a randomized trial comparing oral minocycline alone with minocycline plus photobiomodulation
October 10, 2026

Red Light Therapy for Rosacea: A Thin Evidence Base

Rosacea and red light therapy graded Insufficient: one small add-on trial with oral minocycline, no panel studies, and what would change the grade.

Evidence map of three tendinopathy sources: the 2010 Tumilty meta-analysis, the 2006 Bjordal Achilles trial and the 2022 Naterstad meta-analysis, with their key figures
October 9, 2026

Red Light Therapy for Tendinopathy: The Dose Evidence

Evidence grade Moderate for laser in tendinopathy, with the meta-analyses and trials behind it, what was not studied, and what it means for a home panel.

Chart of pooled pain differences with confidence intervals from the 2022 meta-analysis of laser therapy for lower-limb tendinopathy and plantar fasciitis
October 9, 2026

Study Review: Laser for Plantar Fasciitis and Tendons (2022)

A 2022 BMJ Open meta-analysis of 18 trials on laser for lower-limb tendinopathy and plantar fasciitis, with its dose findings and what they mean for a panel.

Design diagram of the Achilles tendinitis crossover trial showing seven patients, two tendons each, active 904nm laser on one and placebo on the other
October 9, 2026

Study Review: Laser Therapy for Achilles Tendinitis (2006)

A small placebo-controlled crossover trial that measured prostaglandin E2 in the tendon after 904nm laser. What it found, and what it cannot say about a home panel.

Design summary of two 670nm trials in aging eyes, listing population, light exposure and the reported finding for each
October 7, 2026

Study Review: 670nm Light and Aging Vision (2020, 2021)

Two small 670nm trials from one lab reported better color contrast and rod function in adults around 40 and older. Design, limits, and the eye-safety gap to a panel.

Forest plot of pooled effects from the 2025 meta-analysis, showing lower pain at 72 and 96 hours and higher strength at 24 and 48 hours
October 6, 2026

Red Light Therapy for Delayed Onset Muscle Soreness

Evidence grade Limited: two meta-analyses, 2016 and 2025, reached different conclusions on soreness. Trials, wavelengths, what was not studied.

Bar chart of the three ELATED-2 effect sizes on the Hamilton depression scale, 0.75, 0.90 and 1.5, depending on how participants were counted
October 5, 2026

Study Review: ELATED-2, Transcranial NIR for Depression

A sham-controlled pilot of 823nm light on the forehead for major depression: design, dose, the three effect sizes it reported and its caveats.

Design diagram of the 2013 trial showing 20 treated and 20 placebo participants, 1064nm, 250 mW/cm2, 60 J/cm2, forehead
October 5, 2026

Study Review: 1064nm Transcranial Laser and Cognition (2013)

A placebo-controlled study of a 1064nm laser on the forehead of healthy adults: who was studied, the dose, what was measured, and the gap to a home panel.

Design diagram of four trial arms, 830nm, 633nm, combined and sham, treated twice a week for four weeks, with reported maximum wrinkle and elasticity changes
October 4, 2026

Study Review: Split-Face LED Photorejuvenation Trial (2007)

A 2007 split-face trial gave 76 patients 830nm, 633nm, both or a sham light twice a week for four weeks. Design, findings, limits and what a panel can match.

Two forest-style panels showing relative risk of pain improvement and pain scale reduction in millimeters for laser versus placebo in neck pain
October 4, 2026

Study Review: Lancet Meta-Analysis of Laser for Neck Pain

A 2009 Lancet meta-analysis pooled 16 laser trials in 820 patients with neck pain. What it measured, what it found, and what a home panel cannot copy.

Forest-style chart of relative risk of pain improvement for laser versus placebo, 1.69 in acute neck pain and 4.05 in chronic neck pain
October 4, 2026

Red Light Therapy for Neck Pain: The Lancet Meta-Analysis

Grade Moderate. One 2009 Lancet meta-analysis of 16 laser trials and 820 patients, what it found, and what a home panel cannot copy from it.

Three cards showing who was studied, the 810nm treatment parameters and the follow-up design of the 2009 Schiffer pilot
October 3, 2026

Study Review: Single NIR Forehead Session, Depression (2009)

A 10-patient pilot gave one 810nm forehead session and tracked depression and anxiety scores for 4 weeks. What it showed and what it could not.

Three cards comparing the 2009 Schiffer pilot, the 2018 ELATED-2 trial and the 2018 Salehpour review by design, wavelength, placement and dose
October 3, 2026

Transcranial Red and NIR Light for Depression

Grade Limited: a 10-person pilot and a small sham-controlled trial, both using forehead devices at defined doses, not wall panels.

Evidence ladder showing a ram laser study and a testicular heating review sitting below the human trial rungs, which are empty
September 30, 2026

Study Review: The Testosterone Evidence Is a Ram Study and a Heat Review

The only testosterone papers in the register are a ram study and a review of testicular heating. What each covers and why the grade is Insufficient.

Two boxes showing conditions rated Grade B and conditions rated Grade C or D in the Jagdeo 2018 LED dermatology review
September 30, 2026

Study Review: LEDs in Dermatology, 31 Trials

A systematic review of 31 randomized trials graded LED light for acne, herpes and acute wounds higher than other skin conditions. What that means for a panel.

Two bar charts showing girth reduction with laser versus control in the Jackson 2009 and Caruso-Davis 2011 body-contouring trials
September 30, 2026

Study Review: Two Laser Body-Contouring Trials

Jackson 2009 and Caruso-Davis 2011 measured girth after 635nm-range laser sessions. What they found, what they skipped, and why it is not weight loss.

Diagram of the 2018 Zein review, contrasting high-mitochondria tissues that responded to lower doses with low-mitochondria tissues that needed more
September 29, 2026

Study Review: Why Light Parameters Decide Outcomes (2018)

A 2018 review of photobiomodulation parameters found tissues rich in mitochondria responded to lower doses, and that over-dosing explained many failures.

Diagram of the Vanin 2018 review showing 39 trials, 861 participants, 28 pooled trials and four pooled outcomes
September 29, 2026

Study Review: Vanin 2018 Muscle Performance Meta-Analysis

A 2018 review of 39 randomized trials on light therapy and muscle performance in healthy people, what it pooled, and what it means for a home panel.

Bar chart of standardized mean differences for seven outcomes in the 2019 fibromyalgia laser therapy meta-analysis
September 27, 2026

Study Review: Laser Therapy for Fibromyalgia

A 2014 placebo RCT and a 2019 nine-trial meta-analysis on laser therapy for fibromyalgia, and why tender-point dosing is not a panel session.

Trial map comparing population, device, wavelength, dose and outcome across three exercise-performance reviews
September 27, 2026

Red Light Therapy and Sports Performance

Two meta-analyses and one review on phototherapy and exercise performance, graded Moderate, with pre-workout timing and dosing a home panel can copy.

Bar chart of percent hair count increase over baseline, active TOPHAT655 versus sham, in the 2014 female hair growth RCT
September 26, 2026

Study Review: The Lanzafame Female Hair Growth Trial (2014)

The companion trial to the 2013 male study, same helmet device, in 47 women. A 37% hair count increase versus sham, and what differed.

Trial map comparing design, dose and outcome across three fibromyalgia photobiomodulation trials
September 26, 2026

Red Light Therapy for Fibromyalgia: What the Trials Tested

A point-laser RCT, a 9-trial meta-analysis and a whole-body LED bed trial. Grade Moderate, and what home panels cannot copy.

Bar chart of mean lesion improvement for inflammatory lesions and comedones in the Papageorgiou 2000 combined blue-red LED group
September 25, 2026

Study Review: Blue 415nm + Red 660nm Light for Acne (2000)

The foundational four-arm acne trial behind the blue-plus-red case, and why a red-only panel is not the device it tested.

Trial map diagram comparing population size, wavelength, device and follow-up length across four red light and eye health studies
September 24, 2026

Red Light and Eye Health: The 670nm Research, Carefully

Limited evidence from small 670nm vision trials and older AMD studies, all using controlled clinical light sources, not home panels.

Bar chart showing the pooled weighted mean difference in pain score and risk ratio for global improvement from the 2016 low back pain laser therapy meta-analysis
September 23, 2026

Study Review: Laser Therapy for Chronic Low Back Pain, 2016 Meta-Analysis

A 2016 meta-analysis pooled 15 trials and 1,039 patients on low-level laser for chronic back pain. What the dose and duration subgroups actually showed.

Trial map diagram of the 2016 low-level laser therapy meta-analysis for chronic low back pain
September 23, 2026

Red Light Therapy for Back Pain: What the Laser Trials Found

A 2016 meta-analysis of 15 trials found moderate-quality evidence for short-term back pain relief, but only above a laser dose threshold.

Horizontal bar chart comparing periocular wrinkle volume reduction between 660nm red and 590nm amber LED light in the Mota 2023 trial
September 22, 2026

Study Review: 660nm LED for Periocular Wrinkles (2023)

A 137-woman split-face RCT compared 660nm red and 590nm amber LEDs at a matched 3.8 J/cm2 dose. What it found, and what it left out.

Timeline diagram of the 2009 and 2011 Huang biphasic dose response reviews, showing the three lines of cell, molecular and animal evidence the 2011 update adds
September 21, 2026

Study Review: The Biphasic Dose Response Papers

Two mechanistic reviews describe why more light does not mean a better result. What each paper covers, and what it leaves unanswered for a home panel.

Bar chart of lesion improvement percentages from two blue-and-red LED acne trials
September 21, 2026

Red Light Therapy for Acne: What the Combination Trials Show

What two randomized trials on blue-plus-red LED light found for acne, why most home panels lack the blue channel they used, and what has not been tested.

Bar chart comparing the two Wunsch trial light sources on collagen density, skin roughness and photographic improvement outcomes
September 19, 2026

Study Review: The Wunsch Red and Near-Infrared Skin Trial

A 2014 trial treated 113 people twice weekly for 15 weeks with red and red-plus-near-infrared light and measured collagen density and skin roughness.

Forest plot of pooled pain reduction in millimeters across five outcome windows from the Stausholm 2019 knee osteoarthritis meta-analysis
September 18, 2026

Study Review: The Stausholm Knee OA Meta-Analysis

A 2019 pooled analysis of 22 trials and 1,063 patients is the single biggest input to this site's knee osteoarthritis grade. What it pooled and found.

Design diagram of a four-arm knee osteoarthritis trial showing exercise and photobiomodulation combinations, device parameters and outcome measures
September 17, 2026

Study Review: PBM Plus Exercise for Knee Osteoarthritis

A four-arm trial tested light plus leg exercise against exercise alone in women with knee osteoarthritis. What it found, and what it did not.

Bar charts of the two pooled outcomes, time to exhaustion and repetitions, versus placebo
September 16, 2026

Study Review: Phototherapy Before Exercise (2015)

A 2015 meta-analysis pooled 13 higher-quality trials on phototherapy timed around exercise, covering time to exhaustion, repetitions and muscle damage.

Bar chart of Cohen's d effect size for pain reduction from a whole-body photobiomodulation bed versus a sham bed in fibromyalgia, immediately after treatment and at two-week follow-up
September 15, 2026

Study Review: Whole-Body LED Bed for Fibromyalgia

A triple-blinded RCT put 42 women with fibromyalgia in a 660/850nm LED bed for 12 sessions. What the pain scores showed, and the gap to a panel.

Trial design diagram showing the Zhao 2012 whole-body red light sleep study arms, schedule and outcomes
September 14, 2026

Study Review: Red Light, Sleep and Melatonin (2012)

A 14-night, whole-body red-light trial in 20 elite athletes reported better sleep and higher melatonin than placebo. The design, gaps and panel gap.

Bar chart of significance levels for six neuropathy outcome measures after photobiomodulation therapy, with nerve growth factor unchanged
September 14, 2026

Study Review: PBM for Diabetic Neuropathy in 200 Patients

A 200-patient trial tested a helium-neon laser on diabetic neuropathy for ten days. What the biomarkers and pain scores showed, and the gap to a home panel.

Trial design diagram showing the Lanzafame 2013 male hair growth RCT arms, dose and result
September 13, 2026

Study Review: The Lanzafame Male Hair Growth Trial (2013)

A sham-controlled 655nm helmet trial in 44 men found a 39% hair count increase versus sham. The design, the numbers and the panel gap explained.

Bar chart showing 12 of 25 tendinopathy trials found a positive effect and 13 were inconclusive or showed no effect
September 12, 2026

Study Review: Tumilty's Tendinopathy Meta-Analysis

A 2010 meta-analysis of 25 tendon trials found positive results tracked with dosages close to WALT guidelines. Here is what it actually found.

Design diagram of a three-arm knee osteoarthritis trial showing group allocation, wavelength, energy per point and treatment sites
September 12, 2026

Study Review: 790nm Light for Knee Osteoarthritis, WALT Dose

A three-arm randomized trial used 790nm at 4 J per point across nine knee sites. What it reported, what it left out, and what it means for a panel.

Checklist graphic of red light therapy safety cautions covering eyes, heat, medications and pregnancy
September 12, 2026

Is Red Light Therapy Safe? What the Evidence Shows

Reported side effects across red light therapy trials, the tumor-safety review in oncology patients, heat and eye cautions, and what has not been studied.

Bar chart of pain reduction in millimeters on a visual analog scale across dose subgroups in a knee osteoarthritis meta-analysis
September 12, 2026

Red Light for Knee Osteoarthritis: Trials and Meta-Analysis

A meta-analysis of 22 placebo-controlled trials and two randomized trials on knee osteoarthritis, the doses that worked, and what they mean for a home panel.

For a faster route through the most common questions about specific conditions, safety and buying a panel, this site's 40-question FAQ answers each one in a few sentences and links back to the fuller evidence page behind it.